Melinda Lackey
2023
In 2023, Melinda Lackey earned a total compensation of $701.7K as SVP, Legal & Administration at ZIOPHARM Oncology, a 8% decrease compared to previous year.
Compensation breakdown
| Option Awards | $76,620 |
|---|---|
| Salary | $312,084 |
| Other | $313,033 |
| Total | $701,737 |
Lackey received $313K in other compensation, accounting for 45% of the total pay in 2023.
Lackey also received $76.6K in option awards and $312.1K in salary.
Rankings
In 2023, Melinda Lackey's compensation ranked 1,601st out of 2,918 executives tracked by ExecPay. In other words, Lackey earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,601 out of 2,918 | 45th |
Division Manufacturing | 942 out of 1,608 | 41st |
Major group Chemicals And Allied Products | 603 out of 901 | 33rd |
Industry group Drugs | 587 out of 864 | 32nd |
Industry Pharmaceutical Preparations | 416 out of 622 | 33rd |
Source: SEC filing on April 26, 2024.
Lackey's colleagues
We found two more compensation records of executives who worked with Melinda Lackey at ZIOPHARM Oncology in 2023.